RFS
CPRX

Richardson Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History

Richardson Financial Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6K Buy
+1,358
New +$32.4K 0.02% 355
2025
Q3 		– Sell
-525
Closed -$11.1K – 530
2025
Q2 		$11.1K Buy
525
+91
+21% +$2.15K 0.01% 400
2025
Q1 		$10.5K Hold
434
– – 0.01% 376
2024
Q4 		$9.14K Buy
+434
New +$9.32K 0.01% 406
2024
Q1 		– Sell
-493
Closed -$8.29K – 627
2023
Q4 		$8.29K Buy
+493
New +$6.74K 0.01% 325

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Richardson Financial Services's CPRX Position: Q1 2026 in Review

Richardson Financial Services opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 1,358 shares worth $33.6K. The stake represents 0.02% of the portfolio and ranks #355 among its holdings. This is a return to the name: Richardson Financial Services previously reported a position in CPRX as recently as Q2 2025.

Richardson Financial Services first reported a position in CPRX in Q4 2023 and has held it in 5 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Richardson Financial Services held 1,358 shares of Catalyst Pharmaceutical worth $33.6K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Richardson Financial Services position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.02% of Richardson Financial Services's portfolio in Q1 2026, its #355 holding.
  • Richardson Financial Services first reported a position in Catalyst Pharmaceutical in Q4 2023 and has held it in 5 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Richardson Financial Services's 13F filing for Q1 2026, filed 4 May 2026.